P3.04-19 Do Advanced Lung Cancer Patients Derive Similar Survival Benefits From Immunotherapy? A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1726
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Survival Benefits From Follow-Up of Patients With Lung Cancer: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Survival Benefits of Metformin for Colorectal Cancer Patients With Diabetes: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

The Efficacy and Safety of Immunotherapy in Patients With Advanced NSCLC: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2016English

Metformin Use Improves Survival of Diabetic Liver Cancer Patients: Systematic Review and Meta-Analysis

Oncotarget
Oncology
2016English

Palliative Chemotherapy for Advanced Colorectal Cancer: Systematic Review and Meta-Analysis

Annales de Chirurgie
2003English

Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2011English

The Benefits of Modified FOLFIRINOX for Advanced Pancreatic Cancer and Its Induced Adverse Events: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2018English

Prognostic Value of microRNAs in Lung Cancer: A Systematic Review and Meta‑analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

Metformin Use and Survival Outcomes in Endometrial Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy